Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sedia Biosciences has commercialized a portfolio of rapid point-of-care diagnostic assays, epidemiological disease surveillance tools—especially for HIV incidence—and specimen collection devices. Their products are used globally in both resource-rich and resource-limited settings to expand access to infectious disease testing and monitoring. The company holds several patents related to blood/biological sample collection devices. No clinical trial results are reported as their focus is on diagnostics rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sedia Biosciences.